This is the authors' abstract. We don't add key points for this paper.
Point-of-care testing for biomarkers will be the future for a diagnosis of sepsis in the ED, combined with clinical scoring systems.Point of care tests are available for lactates, CRP, procalcitonin, and NGAL.Large, multicenter studies are needed to develop the best bioscore with point of care tests, for rapid and accurate, diagnosis, prognostication, and triaging of patients with sepsis. Orcid
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bhuvana Krishna (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: